JoomFish-Language Selection
2011年的主题 2011年法国宇索生物技术创新奖的重点将放在医疗创新。
资格准则
提交的创新产品必须遵循以下条件：
意向书必须是完整的，在规定时限前以要求的格式提交。
创新将按照下列标准评估。
|
||||||||||||||
Adebiotech
ALMA
Alosta
Alsace Biovalley
Amanda Conrad Translations
Actulabo
Hungarian Biotechnology Association
Px therapeutics
Vivactis Advance
Commission Européenne
Agence Nationale de la recherche
HAS
Inserm
Ministère de l'enseignement supérieur et de la recherche
Angels santé
Cerenis therapeutics
CISS
Fovea pharmaceuticals
IMS Health
Janssen Cilag
Paris Biotech Santé
Pharmaceutiques
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Europharm
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Oxo pharma
Px therapeutics
Px therapeutics
Px therapeutics
RWS GROUP
Px therapeutics
Sigma
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Px therapeutics
Advanstar
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
PMGROUP
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
STP Pharma
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
Adebiotech
